Detection and treatment of atherosclerosis using nanoparticles

Jia Zhang1, Yujiao Zu1, Chathurika S Dhanasekara1

  • 1Department of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA.

Insights

Atherosclerosis, a leading cause of death, involves inflammatory cell buildup in arteries. Nanoparticles show promise for early detection and targeted treatment of this cardiovascular disease.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Nanomedicine

Background:

  • Atherosclerosis is a primary cause of cardiovascular disease and mortality.
  • Early-stage atherosclerosis lacks symptoms and effective detection methods.
  • Current treatments do not specifically target atherosclerotic lesions.

Purpose of the Study:

  • To review the potential of nanoparticles in improving atherosclerosis detection and treatment.
  • To highlight nanoparticle applications in targeting key atherosclerotic processes.

Main Methods:

  • Review of existing literature on nanoparticle applications in atherosclerosis.
  • Analysis of nanoparticle targeting strategies for macrophages, foam cells, and angiogenesis.
  • Evaluation of nanoparticle roles in modulating inflammation, apoptosis, and thrombosis.

Main Results:

  • Nanoparticles can enhance the detection of early-stage atherosclerotic lesions.
  • Targeted nanoparticles can deliver therapeutic agents to specific cells and processes within lesions.
  • Nanoparticles have demonstrated potential in improving blood lipid profiles and reducing inflammation.

Conclusions:

  • Nanoparticles offer a promising platform for advancing atherosclerosis diagnosis and therapy.
  • Targeted nanoparticle delivery can improve treatment efficacy and reduce side effects.
  • Further research into nanoparticle-based interventions is warranted for cardiovascular disease management.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
569
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
559
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
718
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
539
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
835